Total Visits

Views
Adjuvant ...210

Total Visits Per Month

June 2025July 2025August 2025September 2025October 2025November 2025December 2025
Adjuvant ...69554103

File Visits

Views
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021.pdf77
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari8.pdf44
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari1.pdf43
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari9.pdf28
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari5.pdf28
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari6.pdf26
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari7.pdf25
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari2.pdf24
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari4.pdf20
adjuvant_abemaciclib_combined_endocrine_therapy_high_risk_early_breast_cancer_updated_efficacy_ki_67_analysis_monarche_study_2021material_suplementari3.pdf20

Top country views

Views
United States78
Spain40
Singapore21
Brazil15
China12
Germany6
Vietnam6
France5
Finland3
Ireland3

Top cities views

Views
Singapore16
Ashburn15
Madrid9
Barcelona8
Beijing8
Chandler7
Tucson5
Phoenix4
Boardman3
Chicago3